Dr. Sullivan's response to Dr. Toogood's editorial.
Sullivan
T J
TJ
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans
D000319:Adrenergic beta-Antagonists; D006635:Histamine H2 Antagonists